DOUTOR NICHIRES Holdings Yönetim

Yönetim kriter kontrolleri 2/4

DOUTOR NICHIRES Holdings' CEO is Masanori Hoshino, appointed in May 2008, has a tenure of 16.5 years. directly owns 0.048% of the company’s shares, worth ¥46.65M. The average tenure of the management team and the board of directors is 12.5 years and 7 years respectively.

Anahtar bilgiler

Masanori Hoshino

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	16.5yrs
CEO sahipliği	0.05%
Yönetim ortalama görev süresi	12.5yrs
Yönetim Kurulu ortalama görev süresi	7yrs

Son yönetim güncellemeleri

Recent updates

DOUTOR NICHIRES Holdings Co., Ltd.'s (TSE:3087) Share Price Could Signal Some Risk

Aug 08

CEO

Masanori Hoshino (65 yo)

16.5yrs

Görev süresi

Mr. Masanori Hoshino has been the President and Representative Director of DOUTOR NICHIRES Holdings Co., Ltd. since May 2008. He served as the Chairman of DOUTOR NICHIRES Holdings Co., Ltd.since May 2011...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Masanori Hoshino	President & Representative Director	16.5yrs	Veri yok	0.048% ¥ 46.6m
Rokuro Inamori	Managing Director	10.5yrs	Veri yok	Veri yok
Takafumi Kidaka	Managing Director	14.5yrs	Veri yok	Veri yok
Motoya Takebayashi	MD & Director	no data	Veri yok	0.019% ¥ 19.0m
Yasuyuki Tenma	MD & Director	4.5yrs	Veri yok	0.059% ¥ 58.1m

12.5yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim: 3087's management team is seasoned and experienced (12.5 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Masanori Hoshino	President & Representative Director	17.1yrs	Veri yok	0.048% ¥ 46.6m
Motoya Takebayashi	MD & Director	7.5yrs	Veri yok	0.019% ¥ 19.0m
Yasuyuki Tenma	MD & Director	4.5yrs	Veri yok	0.059% ¥ 58.1m
Hirofumi Obayashi	Chairman	17.1yrs	Veri yok	15.49% ¥ 15.2b
Kunio Hashimoto	Full-Time Audit & Supervisory Committee Member	no data	Veri yok	0.023% ¥ 22.8m
Masaharu Kohno	Independent Outside Director	9.5yrs	Veri yok	0.0037% ¥ 3.6m
Tomoyo Goda	Director	8.5yrs	Veri yok	0.033% ¥ 32.0m
Hiroshi Asai	Independent Outside Director	2.5yrs	Veri yok	0.0039% ¥ 3.8m
Kazuhiro Sekine	Director	6.5yrs	Veri yok	0.013% ¥ 13.2m
Seizo Matsumoto	Independent Outside Director	2.5yrs	Veri yok	0.0027% ¥ 2.7m
Kazushige Enoki	Director	1.5yrs	Veri yok	0.0098% ¥ 9.6m

7.0yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3087's board of directors are considered experienced (7 years average tenure).

DOUTOR NICHIRES Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 28, 2024

Less than half of directors are independent

Less than half of directors are independent

DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 25, 2022

Recent updates

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2025 Results on Jan 14, 2025

Second quarter 2025 earnings released: EPS: JP¥41.93 (vs JP¥36.82 in 2Q 2024)

Upcoming dividend of JP¥23.00 per share

DOUTOR NICHIRES Holdings Co., Ltd.'s (TSE:3087) Share Price Could Signal Some Risk

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2025 Results on Oct 15, 2024

First quarter 2025 earnings released: EPS: JP¥54.29 (vs JP¥45.55 in 1Q 2024)

Full year 2024 earnings: EPS misses analyst expectations

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2025 Results on Jul 12, 2024

Price target increased by 9.1% to JP¥2,400

Full year 2024 earnings: EPS misses analyst expectations

DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 28, 2024

Upcoming dividend of JP¥20.00 per share

DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2024 Results on Apr 12, 2024

Third quarter 2024 earnings released: EPS: JP¥30.51 (vs JP¥9.66 in 3Q 2023)

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2024 Results on Jan 12, 2024

Second quarter 2024 earnings released: EPS: JP¥36.82 (vs JP¥28.18 in 2Q 2023)

Upcoming dividend of JP¥20.00 per share at 1.4% yield

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2024 Results on Oct 13, 2023

First quarter 2024 earnings released: EPS: JP¥45.55 (vs JP¥28.99 in 1Q 2023)

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2024 Results on Jul 14, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Price target increased by 15% to JP¥2,300

Price target increased by 21% to JP¥2,300

Full year 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of JP¥16.00 per share at 1.7% yield

DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2023 Results on Apr 14, 2023

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings released: EPS: JP¥9.66 (vs JP¥35.83 in 3Q 2022)

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2023 Results on Jan 13, 2023

Price target increased to JP¥1,900

Less than half of directors are independent

Consensus forecasts updated

Second quarter 2023 earnings released: EPS: JP¥28.18 (vs JP¥16.40 in 2Q 2022)

Upcoming dividend of JP¥14.00 per share

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2023 Results on Oct 14, 2022

Consensus forecasts updated

First quarter 2023 earnings released: EPS: JP¥28.99 (vs JP¥29.95 in 1Q 2022)

Full year 2022 earnings: Revenues miss analyst expectations

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q1, 2023 Results on Jul 15, 2022

Consensus forecasts updated

Less than half of directors are independent

DOUTOR NICHIRES Holdings Co., Ltd., Annual General Meeting, May 25, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of JP¥12.00 per share

DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2022 Results on Apr 14, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings released: EPS JP¥16.40 (vs JP¥30.18 loss in 2Q 2021)

Upcoming dividend of JP¥12.00 per share

First quarter 2022 earnings released: EPS JP¥29.95 (vs JP¥102 loss in 1Q 2021)

Full year 2021 earnings released: JP¥248 loss per share (vs JP¥137 profit in FY 2020)

Full year 2021 earnings released: JP¥248 loss per share (vs JP¥137 profit in FY 2020)

New 90-day high: JP¥1,764

New 90-day high: JP¥1,650

DOUTOR NICHIRES Holdings Co., Ltd. to Report Fiscal Year 2021 Results on Apr 14, 2021

Revenue and earnings miss expectations

Revenue and earnings miss expectations

Third quarter 2021 earnings released: EPS JP¥15.67

New 90-day high: JP¥1,582

Price target lowered to JP¥1,500

New 90-day low: JP¥1,439

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q3, 2021 Results on Jan 14, 2021

DOUTOR NICHIRES Holdings Co., Ltd. to Report Q2, 2021 Results on Oct 15, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş